Effects  ||| S:0 E:8 ||| NNS
of  ||| S:8 E:11 ||| IN
training  ||| S:11 E:20 ||| NN
on  ||| S:20 E:23 ||| IN
equine  ||| S:23 E:30 ||| JJ
muscle  ||| S:30 E:37 ||| NN
fibres  ||| S:37 E:44 ||| NNS
and  ||| S:44 E:48 ||| CC
monocarboxylate  ||| S:48 E:64 ||| JJ
transporters  ||| S:64 E:77 ||| NN
in  ||| S:77 E:80 ||| IN
young  ||| S:80 E:86 ||| JJ
Coldblooded  ||| S:86 E:98 ||| NNP
Trotters  ||| S:98 E:107 ||| NNP
Muscular  ||| S:107 E:116 ||| NNP
changes  ||| S:116 E:124 ||| VBZ
caused  ||| S:124 E:131 ||| VBN
by  ||| S:131 E:134 ||| IN
training  ||| S:134 E:143 ||| NN
are  ||| S:143 E:147 ||| VBP
breed-specific  ||| S:147 E:162 ||| JJ
and  ||| S:162 E:166 ||| CC
studies  ||| S:166 E:174 ||| NNS
on  ||| S:174 E:177 ||| IN
the  ||| S:177 E:181 ||| DT
Norwegian-Swedish  ||| S:181 E:199 ||| JJ
Coldblooded  ||| S:199 E:211 ||| NNP
Trotter  ||| S:211 E:219 ||| NNP
( ||| S:219 E:220 ||| -LRB-
NSCT ||| S:220 E:224 ||| NNP
)  ||| S:224 E:226 ||| -RRB-
are  ||| S:226 E:230 ||| VBP
limited ||| S:230 E:237 ||| VBN
.  ||| S:237 E:239 ||| .
Knowledge  ||| S:239 E:249 ||| NN
about  ||| S:249 E:255 ||| IN
lactate-transporters  ||| S:255 E:276 ||| JJ
in  ||| S:276 E:279 ||| IN
muscle  ||| S:279 E:286 ||| NN
in  ||| S:286 E:289 ||| IN
this  ||| S:289 E:294 ||| DT
light  ||| S:294 E:300 ||| JJ
draught  ||| S:300 E:308 ||| NNS
breed  ||| S:308 E:314 ||| VBP
used  ||| S:314 E:319 ||| VBN
for  ||| S:319 E:323 ||| IN
harness  ||| S:323 E:331 ||| JJ
racing  ||| S:331 E:338 ||| NN
is  ||| S:338 E:341 ||| VBZ
lacking ||| S:341 E:348 ||| VBG
.  ||| S:348 E:350 ||| .
To  ||| S:350 E:353 ||| TO
identify  ||| S:353 E:362 ||| VB
muscular  ||| S:362 E:371 ||| JJ
changes  ||| S:371 E:379 ||| NNS
associated  ||| S:379 E:390 ||| VBN
with  ||| S:390 E:395 ||| IN
training  ||| S:395 E:404 ||| NN
in  ||| S:404 E:407 ||| IN
young  ||| S:407 E:413 ||| JJ
NSCTs  ||| S:413 E:419 ||| JJ
and  ||| S:419 E:423 ||| CC
investigate  ||| S:423 E:435 ||| VB
muscular  ||| S:435 E:444 ||| JJ
distribution  ||| S:444 E:457 ||| NN
of  ||| S:457 E:460 ||| IN
the  ||| S:460 E:464 ||| DT
monocarboxylate  ||| S:464 E:480 ||| JJ
transporter  ||| S:480 E:492 ||| NN
1  ||| S:492 E:494 ||| CD
( ||| S:494 E:495 ||| -LRB-
MCT1 ||| S:495 E:499 ||| NNP
)  ||| S:499 E:501 ||| -RRB-
and  ||| S:501 E:505 ||| CC
its  ||| S:505 E:509 ||| PRP$
ancillary  ||| S:509 E:519 ||| JJ
protein  ||| S:519 E:527 ||| NN
CD147 ||| S:527 E:532 ||| NN
,  ||| S:532 E:534 ||| ,
which  ||| S:534 E:540 ||| WDT
facilitate  ||| S:540 E:551 ||| VBP
lactate  ||| S:551 E:559 ||| JJ
transport  ||| S:559 E:569 ||| NN
across  ||| S:569 E:576 ||| IN
membranes ||| S:576 E:585 ||| NN
.  ||| S:585 E:587 ||| .
Nine  ||| S:587 E:592 ||| CD
horses  ||| S:592 E:599 ||| NNS
were  ||| S:599 E:604 ||| VBD
followed  ||| S:604 E:613 ||| VBN
from  ||| S:613 E:618 ||| IN
the  ||| S:618 E:622 ||| DT
start  ||| S:622 E:628 ||| NN
of  ||| S:628 E:631 ||| IN
their  ||| S:631 E:637 ||| PRP$
training  ||| S:637 E:646 ||| NN
period  ||| S:646 E:653 ||| NN
until  ||| S:653 E:659 ||| IN
the  ||| S:659 E:663 ||| DT
end  ||| S:663 E:667 ||| NN
of  ||| S:667 E:670 ||| IN
their  ||| S:670 E:676 ||| PRP$
3-year-old  ||| S:676 E:687 ||| JJ
season ||| S:687 E:693 ||| NN
.  ||| S:693 E:695 ||| .
A  ||| S:695 E:697 ||| DT
biopsy  ||| S:697 E:704 ||| JJ
sample  ||| S:704 E:711 ||| NN
of  ||| S:711 E:714 ||| IN
the  ||| S:714 E:718 ||| DT
middle  ||| S:718 E:725 ||| JJ
gluteal  ||| S:725 E:733 ||| JJ
muscle  ||| S:733 E:740 ||| NN
was  ||| S:740 E:744 ||| VBD
collected  ||| S:744 E:754 ||| VBN
on  ||| S:754 E:757 ||| IN
4  ||| S:757 E:759 ||| CD
occasions ||| S:759 E:768 ||| NNS
.  ||| S:768 E:770 ||| .
On  ||| S:770 E:773 ||| IN
the  ||| S:773 E:777 ||| DT
last  ||| S:777 E:782 ||| JJ
3  ||| S:782 E:784 ||| CD
sampling  ||| S:784 E:793 ||| CD
occasions ||| S:793 E:802 ||| NNS
,  ||| S:802 E:804 ||| ,
individual  ||| S:804 E:815 ||| JJ
V ||| S:815 E:816 ||| NNP
( ||| S:816 E:817 ||| -LRB-
La4 ||| S:817 E:820 ||| NNP
) ||| S:820 E:821 ||| -RRB-
-values  ||| S:821 E:829 ||| NNP
( ||| S:829 E:830 ||| -LRB-
the  ||| S:830 E:834 ||| DT
speed  ||| S:834 E:840 ||| NN
corresponding  ||| S:840 E:854 ||| NN
to  ||| S:854 E:857 ||| TO
a  ||| S:857 E:859 ||| DT
blood  ||| S:859 E:865 ||| NN
lactate  ||| S:865 E:873 ||| NN
concentration  ||| S:873 E:887 ||| NN
of  ||| S:887 E:890 ||| IN
4  ||| S:890 E:892 ||| CD
mmol ||| S:892 E:896 ||| CD
/ ||| S:896 E:897 ||| CD
l ||| S:897 E:898 ||| CD
)  ||| S:898 E:900 ||| -RRB-
were  ||| S:900 E:905 ||| VBD
determined  ||| S:905 E:916 ||| VBN
in  ||| S:916 E:919 ||| IN
an  ||| S:919 E:922 ||| DT
incremental  ||| S:922 E:934 ||| JJ
exercise  ||| S:934 E:943 ||| NN
test  ||| S:943 E:948 ||| NN
on  ||| S:948 E:951 ||| IN
a  ||| S:951 E:953 ||| DT
high-speed  ||| S:953 E:964 ||| JJ
treadmill ||| S:964 E:973 ||| NN
.  ||| S:973 E:975 ||| .
One  ||| S:975 E:979 ||| CD
horse  ||| S:979 E:985 ||| NN
was  ||| S:985 E:989 ||| VBD
excluded  ||| S:989 E:998 ||| VBN
due  ||| S:998 E:1002 ||| JJ
to  ||| S:1002 E:1005 ||| TO
lameness ||| S:1005 E:1013 ||| VB
.  ||| S:1013 E:1015 ||| .
Histochemical  ||| S:1015 E:1029 ||| NNP
and  ||| S:1029 E:1033 ||| CC
immunohistochemical  ||| S:1033 E:1053 ||| JJ
analyses  ||| S:1053 E:1062 ||| NNS
were  ||| S:1062 E:1067 ||| VBD
performed  ||| S:1067 E:1077 ||| VBN
on  ||| S:1077 E:1080 ||| IN
all  ||| S:1080 E:1084 ||| DT
muscle  ||| S:1084 E:1091 ||| NN
samples  ||| S:1091 E:1099 ||| NNS
to  ||| S:1099 E:1102 ||| TO
determine  ||| S:1102 E:1112 ||| VB
fibre  ||| S:1112 E:1118 ||| JJ
types  ||| S:1118 E:1124 ||| NNS
( ||| S:1124 E:1125 ||| -LRB-
I ||| S:1125 E:1126 ||| PRP
,  ||| S:1126 E:1128 ||| ,
IIA ||| S:1128 E:1131 ||| NNP
,  ||| S:1131 E:1133 ||| ,
IIAX ||| S:1133 E:1137 ||| NNP
,  ||| S:1137 E:1139 ||| ,
IIX ||| S:1139 E:1142 ||| NNP
) ||| S:1142 E:1143 ||| -RRB-
,  ||| S:1143 E:1145 ||| ,
oxidative  ||| S:1145 E:1155 ||| JJ
capacity  ||| S:1155 E:1164 ||| NN
( ||| S:1164 E:1165 ||| -LRB-
NADH ||| S:1165 E:1169 ||| NNP
)  ||| S:1169 E:1171 ||| -RRB-
and  ||| S:1171 E:1175 ||| CC
the  ||| S:1175 E:1179 ||| DT
expression  ||| S:1179 E:1190 ||| NN
of  ||| S:1190 E:1193 ||| IN
MCT1  ||| S:1193 E:1198 ||| NNP
and  ||| S:1198 E:1202 ||| CC
CD147 ||| S:1202 E:1207 ||| NNP
.  ||| S:1207 E:1209 ||| .
The  ||| S:1209 E:1213 ||| DT
activity  ||| S:1213 E:1222 ||| NN
of  ||| S:1222 E:1225 ||| IN
selected  ||| S:1225 E:1234 ||| JJ
metabolic  ||| S:1234 E:1244 ||| JJ
enzymes  ||| S:1244 E:1252 ||| NN
in  ||| S:1252 E:1255 ||| IN
the  ||| S:1255 E:1259 ||| DT
muscle  ||| S:1259 E:1266 ||| NN
before  ||| S:1266 E:1273 ||| IN
and  ||| S:1273 E:1277 ||| CC
after  ||| S:1277 E:1283 ||| IN
training  ||| S:1283 E:1292 ||| NN
was  ||| S:1292 E:1296 ||| VBD
determined ||| S:1296 E:1306 ||| VBN
.  ||| S:1306 E:1308 ||| .
The  ||| S:1308 E:1312 ||| DT
percentage  ||| S:1312 E:1323 ||| NN
of  ||| S:1323 E:1326 ||| IN
type  ||| S:1326 E:1331 ||| NN
IIX  ||| S:1331 E:1335 ||| NNS
fibres  ||| S:1335 E:1342 ||| VBP
decreased  ||| S:1342 E:1352 ||| VBN
with  ||| S:1352 E:1357 ||| IN
training  ||| S:1357 E:1366 ||| NN
while  ||| S:1366 E:1372 ||| IN
the  ||| S:1372 E:1376 ||| DT
percentage  ||| S:1376 E:1387 ||| NN
of  ||| S:1387 E:1390 ||| IN
type  ||| S:1390 E:1395 ||| NN
IIAX  ||| S:1395 E:1400 ||| NNS
fibres  ||| S:1400 E:1407 ||| VBP
increased ||| S:1407 E:1416 ||| VBN
.  ||| S:1416 E:1418 ||| .
The  ||| S:1418 E:1422 ||| DT
activity  ||| S:1422 E:1431 ||| NN
of  ||| S:1431 E:1434 ||| IN
citrate  ||| S:1434 E:1442 ||| JJ
synthase  ||| S:1442 E:1451 ||| NN
and  ||| S:1451 E:1455 ||| CC
3-OH-acyl-CoA-dehydrogenase  ||| S:1455 E:1483 ||| NNP
increased  ||| S:1483 E:1493 ||| VBD
with  ||| S:1493 E:1498 ||| IN
training ||| S:1498 E:1506 ||| NN
.  ||| S:1506 E:1508 ||| .
The  ||| S:1508 E:1512 ||| DT
expression  ||| S:1512 E:1523 ||| NN
of  ||| S:1523 E:1526 ||| IN
MCT1  ||| S:1526 E:1531 ||| NNP
was  ||| S:1531 E:1535 ||| VBD
lower  ||| S:1535 E:1541 ||| JJR
in  ||| S:1541 E:1544 ||| IN
membranes  ||| S:1544 E:1554 ||| NN
and  ||| S:1554 E:1558 ||| CC
cytoplasm  ||| S:1558 E:1568 ||| NN
of  ||| S:1568 E:1571 ||| IN
type  ||| S:1571 E:1576 ||| NN
IIX  ||| S:1576 E:1580 ||| NNS
fibres  ||| S:1580 E:1587 ||| VBP
compared  ||| S:1587 E:1596 ||| VBN
to  ||| S:1596 E:1599 ||| TO
all  ||| S:1599 E:1603 ||| DT
other  ||| S:1603 E:1609 ||| JJ
fibre  ||| S:1609 E:1615 ||| JJ
types  ||| S:1615 E:1621 ||| NNS
both  ||| S:1621 E:1626 ||| CC
before  ||| S:1626 E:1633 ||| RB
and  ||| S:1633 E:1637 ||| CC
after  ||| S:1637 E:1643 ||| IN
training ||| S:1643 E:1651 ||| NN
.  ||| S:1651 E:1653 ||| .
The  ||| S:1653 E:1657 ||| DT
antibody  ||| S:1657 E:1666 ||| NN
against  ||| S:1666 E:1674 ||| IN
CD147  ||| S:1674 E:1680 ||| CD
stained  ||| S:1680 E:1688 ||| CD
membranes  ||| S:1688 E:1698 ||| NNS
and  ||| S:1698 E:1702 ||| CC
cytoplasm  ||| S:1702 E:1712 ||| NN
of  ||| S:1712 E:1715 ||| IN
all  ||| S:1715 E:1719 ||| DT
fibres ||| S:1719 E:1725 ||| NN
.  ||| S:1725 E:1727 ||| .
The  ||| S:1727 E:1731 ||| DT
first  ||| S:1731 E:1737 ||| JJ
V ||| S:1737 E:1738 ||| NNP
( ||| S:1738 E:1739 ||| -LRB-
La4 ||| S:1739 E:1742 ||| NNP
) ||| S:1742 E:1743 ||| -RRB-
-value  ||| S:1743 E:1750 ||| NNP
was  ||| S:1750 E:1754 ||| VBD
lower  ||| S:1754 E:1760 ||| JJR
than  ||| S:1760 E:1765 ||| IN
the  ||| S:1765 E:1769 ||| DT
last  ||| S:1769 E:1774 ||| JJ
2  ||| S:1774 E:1776 ||| CD
in  ||| S:1776 E:1779 ||| IN
all  ||| S:1779 E:1783 ||| DT
horses ||| S:1783 E:1789 ||| NNS
.  ||| S:1789 E:1791 ||| .
Muscular  ||| S:1791 E:1800 ||| JJ
changes  ||| S:1800 E:1808 ||| NNS
with  ||| S:1808 E:1813 ||| IN
training  ||| S:1813 E:1822 ||| NN
of  ||| S:1822 E:1825 ||| IN
NSCTs  ||| S:1825 E:1831 ||| NNP
were  ||| S:1831 E:1836 ||| VBD
similar  ||| S:1836 E:1844 ||| JJ
to  ||| S:1844 E:1847 ||| TO
those  ||| S:1847 E:1853 ||| DT
reported  ||| S:1853 E:1862 ||| VBN
in  ||| S:1862 E:1865 ||| IN
Standardbreds ||| S:1865 E:1878 ||| NNP
,  ||| S:1878 E:1880 ||| ,
indicating  ||| S:1880 E:1891 ||| VBG
fibre  ||| S:1891 E:1897 ||| JJ
type  ||| S:1897 E:1902 ||| NN
transitions  ||| S:1902 E:1914 ||| NNS
and  ||| S:1914 E:1918 ||| CC
increased  ||| S:1918 E:1928 ||| VBD
oxidative  ||| S:1928 E:1938 ||| JJ
capacity ||| S:1938 E:1946 ||| NN
.  ||| S:1946 E:1948 ||| .
Expression  ||| S:1948 E:1959 ||| NN
of  ||| S:1959 E:1962 ||| IN
MCT1  ||| S:1962 E:1967 ||| CD
differed  ||| S:1967 E:1976 ||| NN
among  ||| S:1976 E:1982 ||| IN
fibre  ||| S:1982 E:1988 ||| JJ
types  ||| S:1988 E:1994 ||| NNS
and  ||| S:1994 E:1998 ||| CC
was  ||| S:1998 E:2002 ||| VBD
related  ||| S:2002 E:2010 ||| VBN
to  ||| S:2010 E:2013 ||| TO
the  ||| S:2013 E:2017 ||| DT
oxidative  ||| S:2017 E:2027 ||| JJ
capacity  ||| S:2027 E:2036 ||| NN
of  ||| S:2036 E:2039 ||| IN
the  ||| S:2039 E:2043 ||| DT
fibres ||| S:2043 E:2049 ||| NN
.  ||| S:2049 E:2051 ||| .
